Ravicti (Hyperion Therapeutics, Inc.)
Welcome to the PulseAid listing for the Ravicti drug offered from Hyperion Therapeutics, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hyperion Therapeutics, Inc. |
| NON-PROPRIETARY NAME: | glycerol phenylbutyrate |
| SUBSTANCE NAME: | GLYCEROL PHENYLBUTYRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-02-28 |
| END MARKETING DATE: | 0000-00-00 |
Ravicti HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ravicti from Hyperion Therapeutics, Inc. |
| LABELER NAME: | Hyperion Therapeutics, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.1(g/mL) |
| START MARKETING DATE: | 2013-02-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76325-100_e3f10bc0-6ed9-11e2-bcfd-0800200c9a66 |
| PRODUCT NDC: | 76325-100 |
| APPLICATION NUMBER: | NDA203284 |
Other GLYCEROL PHENYLBUTYRATE Pharmaceutical Manufacturers / Labelers:
